A comparative pharmaceutico analytical and clinical study of Rasnasaptak Kashaya And Rasnapanchak Kashaya Ghanvati in Amavata w.s.r.to Rheumatoid Arthritis
Trial Snapshot
- Phase
- Phase 2/3
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Subjective Parameter- Grading will be done with sign & symptoms of Amavata
Study Overview
Brief Summary
In this trial we are selecting patients of Amavata in two groups, in which we will do intervention study of study with Rasnasaptak kashaya ghanvati and Rasnapanchak kashaya ghanvati with the dose of two tablets of 500 mg BD assesment will be done on the subjective and objective parameters for the Amavata.
Route of Drug Adminitration - Oral
Follow up- Day 10, day 20, day 30
Study Design
- Study Type
- Interventional
- Allocation
- Not Applicable
- Masking
- Open Label
Eligibility Criteria
- Ages
- 20.00 Year(s) to 70.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Patient willing for trial
- •Either Sex will be selected
- •Newly Diagnosed case and patient not on any medication since one month will be selected
- •Patient having classical symptoms of Rheumatoid Arthritis will be Selected.
Exclusion Criteria
- •Age more than 70 yrs and less than 20 yrs.
- •Patient not willing for trial.
- •Pregnancy and lactating mothers
- •Patients suffering from any known case of severe systemic disorder like Crohn Disease, SLE, Graves disease, AIDS etc, which may interfere with the course of treatment will be excluded.
Outcomes
Primary Outcomes
Subjective Parameter- Grading will be done with sign & symptoms of Amavata
Time Frame: After one month intervention of Rasnasaptak kashaya Ghanvati and Rasnapanchak kashaya Ghanvati orally.
RA factor,ESR,CRP,SGOT,SGPT,Uric Acid,HB,TLC to rule out other pathologies
Time Frame: After one month intervention of Rasnasaptak kashaya Ghanvati and Rasnapanchak kashaya Ghanvati orally.
Secondary Outcomes
- Subjective parameter-grading will be done with sign & symptoms of Amavata RA factor, ESR,CRP,SGOT,SGPT,Uric acid,HB(After one mmonth intervention of Rasnasaptak Kashaya Ghanvati & Rasnapanchak Kashaya Ghanvati)